Chang‐Uk Lim

901 total citations
21 papers, 533 citations indexed

About

Chang‐Uk Lim is a scholar working on Molecular Biology, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Chang‐Uk Lim has authored 21 papers receiving a total of 533 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 10 papers in Oncology and 5 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Chang‐Uk Lim's work include Cancer-related Molecular Pathways (6 papers), DNA Repair Mechanisms (5 papers) and Advanced Breast Cancer Therapies (4 papers). Chang‐Uk Lim is often cited by papers focused on Cancer-related Molecular Pathways (6 papers), DNA Repair Mechanisms (5 papers) and Advanced Breast Cancer Therapies (4 papers). Chang‐Uk Lim collaborates with scholars based in United States, Russia and Australia. Chang‐Uk Lim's co-authors include Eugenia V. Broude, Igor B. Roninson, Michael H. Fox, Jiaxin Liang, Mengqian Chen, Alexander A. Chumanevich, Serena Altilia, Martina S.J. McDermott, Hippokratis Kiaris and Michael Shtutman and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Cancer Research and Biochemical Journal.

In The Last Decade

Chang‐Uk Lim

20 papers receiving 528 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Chang‐Uk Lim United States	13	343	176	90	87	70	21	533
Minalini Lakshman Canada	7	299 0.9×	205 1.2×	63 0.7×	115 1.3×	79 1.1×	9	529
Marica Gemei Italy	17	371 1.1×	248 1.4×	58 0.6×	199 2.3×	52 0.7×	30	666
Eun Ji Ro South Korea	10	412 1.2×	265 1.5×	54 0.6×	102 1.2×	45 0.6×	12	633
Jeong Yong Jeon South Korea	15	316 0.9×	116 0.7×	41 0.5×	166 1.9×	49 0.7×	20	559
Xinhui Wang China	12	330 1.0×	150 0.9×	51 0.6×	95 1.1×	53 0.8×	30	516
Shishan Deng China	13	390 1.1×	135 0.8×	58 0.6×	177 2.0×	67 1.0×	31	520
BaoHan T. Vo United States	12	335 1.0×	114 0.6×	77 0.9×	107 1.2×	38 0.5×	15	502
Miaofeng Zhang China	9	421 1.2×	155 0.9×	61 0.7×	144 1.7×	30 0.4×	13	613
LaTonia Taliaferro‐Smith United States	8	362 1.1×	240 1.4×	84 0.9×	159 1.8×	55 0.8×	13	556
Maider Ibarrola‐Villava Spain	16	310 0.9×	214 1.2×	52 0.6×	136 1.6×	185 2.6×	31	658

Countries citing papers authored by Chang‐Uk Lim

Since Specialization

Citations

This map shows the geographic impact of Chang‐Uk Lim's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chang‐Uk Lim with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chang‐Uk Lim more than expected).

Fields of papers citing papers by Chang‐Uk Lim

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chang‐Uk Lim. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chang‐Uk Lim. The network helps show where Chang‐Uk Lim may publish in the future.

Co-authorship network of co-authors of Chang‐Uk Lim

This figure shows the co-authorship network connecting the top 25 collaborators of Chang‐Uk Lim. A scholar is included among the top collaborators of Chang‐Uk Lim based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chang‐Uk Lim. Chang‐Uk Lim is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Vorobyeva, Nadezhda E., Alexander Tyakht, Jing Li, et al.. (2025). CDK8/19 inhibition attenuates G1 arrest induced by BCR-ABL antagonists and accelerates death of chronic myelogenous leukemia cells. Cell Death Discovery. 11(1). 62–62.

Sharko, Amanda C., Xiaokai Ding, Chang‐Uk Lim, et al.. (2022). Abstract P4-01-17: Preventing adaptive therapeutic resistance to CDK4/6 inhibition with CDK8/19 inhibitors. Cancer Research. 82(4_Supplement). P4–1. 1 indexed citations

Zhang, Youwen, Chang‐Uk Lim, Vitali Sikirzhytski, et al.. (2021). Propensity to endoplasmic reticulum stress in deer mouse fibroblasts predicts skin inflammation and body weight gain. Disease Models & Mechanisms. 14(10). 1 indexed citations

McDermott, Martina S.J., et al.. (2020). CDK7 Inhibition Is Effective in all the Subtypes of Breast Cancer: Determinants of Response and Synergy with EGFR Inhibition. Cells. 9(3). 638–638. 26 indexed citations

Liang, Jiaxin, Mengqian Chen, Daniel Hughes, et al.. (2018). CDK8 Selectively Promotes the Growth of Colon Cancer Metastases in the Liver by Regulating Gene Expression of TIMP3 and Matrix Metalloproteinases. Cancer Research. 78(23). 6594–6606. 68 indexed citations

McDermott, Martina S.J., Alexander A. Chumanevich, Chang‐Uk Lim, et al.. (2017). Inhibition of CDK8 mediator kinase suppresses estrogen dependent transcription and the growth of estrogen receptor positive breast cancer. Oncotarget. 8(8). 12558–12575. 94 indexed citations

Liang, Jiaxin, Mengqian Chen, Karthikeyan Mythreye, et al.. (2017). Abstract 4896: Role of CDK8 in colon cancer hepatic metastasis. Cancer Research. 77(13_Supplement). 4896–4896. 1 indexed citations

Levina, Elina, Hao Ji, Mirza S. Baig, et al.. (2015). Identification of novel genes that regulate androgen receptor signaling and growth of androgen-deprived prostate cancer cells. Oncotarget. 6(15). 13088–13104. 16 indexed citations

Porter, Donald C., Christopher G. Danes, Bey-Dih Chang, et al.. (2012). Abstract 1820: CDK3: A novel tumor-selective drug target involved in AP1 activation and transcriptional damage response. Cancer Research. 72(8_Supplement). 1820–1820. 1 indexed citations

10.

Glinskii, Anna B., Shuang Ma, Chang‐Uk Lim, et al.. (2011). Networks of intergenic long-range enhancers and snpRNAs drive castration-resistant phenotype of prostate cancer and contribute to pathogenesis of multiple common human disorders. Cell Cycle. 10(20). 3571–3597. 20 indexed citations

11.

Lim, Chang‐Uk, et al.. (2011). Effects of conditional depletion of topoisomerase II on cell cycle progression in mammalian cells. Cell Cycle. 10(20). 3505–3514. 30 indexed citations

12.

Shtutman, Michael, Mirza S. Baig, Elina Levina, et al.. (2011). Tumor-specific silencing ofCOPZ2gene encoding coatomer protein complex subunit ζ2 renders tumor cells dependent on its paralogous geneCOPZ1. Proceedings of the National Academy of Sciences. 108(30). 12449–12454. 44 indexed citations

13.

Lin, Hung‐Yun, Cornelia B. Landersdorfer, David London, et al.. (2011). Pharmacodynamic Modeling of Anti-Cancer Activity of Tetraiodothyroacetic Acid in a Perfused Cell Culture System. PLoS Computational Biology. 7(2). e1001073–e1001073. 76 indexed citations

14.

Ossovskaya, Valeria, Chang‐Uk Lim, Gary P. Schools, et al.. (2011). Abstract LB-401: The chemosensitizing properties of iniparib in combination with DNA-damaging agents in the MDA-MB-468(−) triple-negative breast cancer (TNBC) cell line. Cancer Research. 71(8_Supplement). LB–401. 7 indexed citations

15.

Ossovskaya, Valeria, Lingyun Li, Eugenia V. Broude, et al.. (2009). Abstract #5552: BSI-201 enhances the activity of multiple classes of cytotoxic agents and irradiation in triple negative breast cancer. Cancer Research. 69. 5552–5552. 13 indexed citations

16.

Glinskii, Anna B., et al.. (2009). Identification of intergenic trans-regulatory RNAs containing a disease-linked SNP sequence and targeting cell cycle progression/differentiation pathways in multiple common human disorders. Cell Cycle. 8(23). 3925–3942. 51 indexed citations

17.

Lim, Chang‐Uk, Ying Zhang, & Michael H. Fox. (2006). Cell cycle dependent apoptosis and cell cycle blocks induced by hyperthermia in HL-60 cells. International Journal of Hyperthermia. 22(1). 77–91. 24 indexed citations

18.

Keysar, Stephen B., et al.. (2006). Comparison of the mutagenic potential of 17 physical and chemical agents analyzed by the flow cytometry mutation assay. Mutation research. Fundamental and molecular mechanisms of mutagenesis. 602(1-2). 14–25. 10 indexed citations

19.

Lim, Chang‐Uk, et al.. (2005). Assay to measure CD59 mutations in CHO A_L cells using flow cytometry. Cytometry Part A. 66A(2). 85–90. 10 indexed citations

20.

Chamberlain, M., Liping Wang, Shawn G. Payne, et al.. (2005). Effect of a membrane-targeted sphingosine kinase 1 on cell proliferation and survival. Biochemical Journal. 388(3). 827–834. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact